BRIM (6885) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 全福生技

BRIM (6885) reported revenue of NT$1.5 million for Oct 2026, +74.9% year on year and +19.6% from the previous month. Revenue for Jan–Oct 2026 was NT$11.4 million (+205.1% year on year).

Year-on-year revenue growth: 5 months in a row. →

In Oct 2026, it ranked No. 147 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$33,00024/10Nov 2024 NT$201,000Dec 2024 NT$33,000Jan 2025 NT$33,000Feb 2025 NT$34,00025/02Mar 2025 NT$33,000Apr 2025 NT$34,000May 2025 NT$1.1 millionJun 2025 NT$402,00025/06Jul 2025 NT$402,000Aug 2025 NT$429,000Sep 2025 NT$398,000Oct 2025 NT$843,00025/10Nov 2025 NT$679,000Dec 2025 NT$1.1 millionJan 2026 NT$987,000Feb 2026 NT$632,00026/02Mar 2026 NT$1.2 millionApr 2026 NT$766,000May 2026 NT$822,000Jun 2026 NT$2.4 million26/06Jul 2026 NT$839,000Aug 2026 NT$1.1 millionSep 2026 NT$1.2 millionOct 2026 NT$1.5 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$1.5 million+74.9%+19.6%
Sep 2026NT$1.2 million+209.5%+11.7%
Aug 2026NT$1.1 million+157.1%+31.5%
Jul 2026NT$839,000+108.7%-64.7%
Jun 2026NT$2.4 million+491.5%+189.3%
May 2026NT$822,000-27.9%+7.3%
Apr 2026NT$766,000+2,152.9%-36.4%
Mar 2026NT$1.2 million+3,548.5%+90.5%
Feb 2026NT$632,000+1,758.8%-36.0%
Jan 2026NT$987,000+2,890.9%-7.1%
Dec 2025NT$1.1 million+3,121.2%+56.6%
Nov 2025NT$679,000+237.8%-19.5%
Oct 2025NT$843,000+2,454.5%+111.8%
Sep 2025NT$398,000+1,106.1%-7.2%
Aug 2025NT$429,000+1,200.0%+6.7%
Jul 2025NT$402,000—+0.0%
Jun 2025NT$402,000—-64.7%
May 2025NT$1.1 million—+3,252.9%
Apr 2025NT$34,000—+3.0%
Mar 2025NT$33,000—-2.9%
Feb 2025NT$34,000—+3.0%
Jan 2025NT$33,000—+0.0%
Dec 2024NT$33,000-63.3%-83.6%
Nov 2024NT$201,000—+509.1%
Oct 2024NT$33,000—+0.0%

Jan–Oct 2026 cumulative: NT$11.4 million (+205.1% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: BRIM vs PEC / BRIM vs Lotus Pharm / BRIM vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

諮詢服務收入、含子公司營業收入

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16